NanoViricides Accounts Payable from 2010 to 2024
| NNVC Stock | USD 1.12 0.02 1.82% |
Accounts Payable | First Reported 2006-06-30 | Previous Quarter 157.1 K | Current Value 770.7 K | Quarterly Volatility 312.2 K |
Check NanoViricides financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NanoViricides main balance sheet or income statement drivers, such as Interest Expense of 1 K, Other Operating Expenses of 7 M or Research Development of 4.2 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 3.34 or PTB Ratio of 0.77. NanoViricides financial statements analysis is a perfect complement when working with NanoViricides Valuation or Volatility modules.
NanoViricides | Accounts Payable |
Latest NanoViricides' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of NanoViricides over the last few years. An accounting item on the balance sheet that represents NanoViricides obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NanoViricides are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. NanoViricides' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NanoViricides' overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
NanoViricides Accounts Payable Regression Statistics
| Arithmetic Mean | 223,891 | |
| Geometric Mean | 179,230 | |
| Coefficient Of Variation | 67.11 | |
| Mean Deviation | 115,332 | |
| Median | 200,016 | |
| Standard Deviation | 150,245 | |
| Sample Variance | 22.6B | |
| Range | 555.6K | |
| R-Value | (0.21) | |
| Mean Square Error | 23.3B | |
| R-Squared | 0.04 | |
| Significance | 0.46 | |
| Slope | (6,888) | |
| Total Sum of Squares | 316B |
NanoViricides Accounts Payable History
About NanoViricides Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include NanoViricides income statement, its balance sheet, and the statement of cash flows. NanoViricides investors use historical funamental indicators, such as NanoViricides's Accounts Payable, to determine how well the company is positioned to perform in the future. Although NanoViricides investors may use each financial statement separately, they are all related. The changes in NanoViricides's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on NanoViricides's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on NanoViricides Financial Statements. Understanding these patterns can help to make the right decision on long term investment in NanoViricides. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 141.3 K | 274 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of NanoViricides Correlation against competitors. For information on how to trade NanoViricides Stock refer to our How to Trade NanoViricides Stock guide.You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for NanoViricides Stock analysis
When running NanoViricides' price analysis, check to measure NanoViricides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoViricides is operating at the current time. Most of NanoViricides' value examination focuses on studying past and present price action to predict the probability of NanoViricides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoViricides' price. Additionally, you may evaluate how the addition of NanoViricides to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
Is NanoViricides' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoViricides. If investors know NanoViricides will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoViricides listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Return On Assets (0.36) | Return On Equity (0.58) |
The market value of NanoViricides is measured differently than its book value, which is the value of NanoViricides that is recorded on the company's balance sheet. Investors also form their own opinion of NanoViricides' value that differs from its market value or its book value, called intrinsic value, which is NanoViricides' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoViricides' market value can be influenced by many factors that don't directly affect NanoViricides' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoViricides' value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoViricides is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoViricides' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.